Darolutamide in nmCRPC
Oncología

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Fizazi K, et al. N Engl J Med. 2019;380:1235–1246

Related Content
nmCRPC and Survival with Darolutamide
CPRCnm
OS and AEs with darolutamide vs apalutamide vs enzalutamide
CPRCnm
Treating the patient and not just the cancer
Cáncer de próstata